CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tuberculosis Vaccine Candidate

Overview of attention for article published in Frontiers in immunology, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 35,792 followers.

RT @FrontImmunol: New Research: CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tu…

RT @FrontImmunol: New Research: CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tu…

RT @FrontImmunol: New Research: CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tu…

RT @FrontImmunol: New Research: CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tu…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.